BAYFIDAN TURF

Main information

  • Trade name:
  • BAYFIDAN TURF FUNGICIDE
  • Pharmaceutical form:
  • Emulsifiable
  • Units in package:
  • 1L
  • Class:
  • AgChem
  • Medicine domain:
  • Equipment
  • Medicine type:
  • Agrochemical
  • Manufactured by:
  • BAYER CROPSCIENCE

Documents

Localization

  • Available in:
  • BAYFIDAN TURF FUNGICIDE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • TURF
  • Therapeutic area:
  • Group 3 Fungicide
  • Therapeutic indications:
  • BLACK HELMINTHOSPORIUM | DOLLAR SPOT | FUSARIUM TURF PATCH | TAKE-ALL PATCH
  • Product summary:
  • For systemic control of dollar spot and other diseases of turf.DO NOT apply earlier than 5 weeks after sowing

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 30676/1005
  • Authorization date:
  • 06-10-2005
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Current Reg - Oct

2005

Bayfidan Turf Fungicide Liquid

Page 1 of 5

MAIN PANEL

POISON

KEEP OUT OF REACH OF CHILDREN

READ SAFETY DIRECTIONS BEFORE OPENING OR USING

Bayfidan

®

TURF FUNGICIDE

ACTIVE CONSTITUENT: 250 g/L TRIADIMENOL

SOLVENT: 602 g/L N-METHYL-2-PYRROLIDONE

GROUP

C

FUNGICIDE

For the systemic control of dollar spot and other diseases of turf as

specified in the directions for use table

IMPORTANT: READ THE ATTACHED BOOKLET BEFORE USE

(label code)

Info

pest

Verified

Info

pest

Verified

Current Reg - Oct

2005

Bayfidan Turf Fungicide Liquid

Page 2 of 5

FRONT PAGE OF BOOKLET

POISON

KEEP OUT OF REACH OF CHILDREN

READ SAFETY DIRECTIONS BEFORE OPENING OR USING

Bayfidan

®

TURF FUNGICIDE

ACTIVE CONSTITUENT: 250 g/L TRIADIMENOL

SOLVENT: 602 g/L N-METHYL-2-PYRROLIDONE

GROUP

C

FUNGICIDE

For the systemic control of dollar spot and other diseases of turf as

specified in the directions for use table

IMPORTANT: READ THIS BOOKLET BEFORE USE

(label code)

Current Reg - Oct

2005

Bayfidan Turf Fungicide Liquid

Page 3 of 5

BOOKLET

_____________________________________________________________________

Protection of Crops, Native and Non-target Plants

Do not apply earlier than 5 weeks after sowing.

Protection of Wildlife, Fish, Crustaceans and Environment

Harmful to fish. DO NOT contaminate streams, rivers or waterways with the chemical or

used containers.

Storage and Disposal

Store in the closed, original container in a cool, well ventilated area. Do not store for

prolonged periods in direct sunlight. Rinse containers before disposal. Add rinsings to spray

tank. Do not dispose of undiluted chemicals on site. Dispose of at local authority landfill. If

no landfill is available, bury the container below 500 mm in a disposal pit specifically marked

and set up for this purpose clear of waterways, desirable vegetation and tree roots. Empty

containers and product should not be burnt.

Safety Directions

Will irritate the eyes and skin. Avoid contact with eyes and skin. Do not inhale spray mist.

When preparing spray, wear cotton overalls buttoned to the neck and wrist, a washable hat,

elbow-length butyl rubber gloves and goggles. If product in eyes, wash it out immediately

with water. After use and before eating, drinking or smoking, wash hands, arms and face

thoroughly

with

soap

water.

After

each

day's

use,

wash

gloves,

goggles

contaminated clothing.

First Aid

If poisoning occurs, contact a doctor or Poisons Information Centre (Phone Australia:

131126).

Material Safety Data Sheet

Additional information is listed in the Material Safety Data Sheet

Exclusion of Liability

This product must be used strictly as directed, and in accordance with all instructions

appearing on the label and in other reference material. So far as it is lawfully able to do so,

Bayer CropScience Pty Ltd accepts no liability or responsibility for loss or damage arising

from failure to follow such directions and instructions.

Bayfidan

and Baythroid

are Registered Trademarks of Bayer.

APVMA Approval No.: 30676/1 L/1005

Bayer Environmental Science

Bayer CropScience Pty Ltd

A.B.N. 87 000 226 022

391-393 Tooronga Rd

East Hawthorn Vic. 3123

Phone: (03) 9248 6888

Fax: (03) 9248 6800

Website: www.bayercropscience.com.au

Current Reg - Oct

2005

Bayfidan Turf Fungicide Liquid

Page 4 of 5

BOOKLET contd

_____________________________________________________________________

DIRECTIONS FOR USE

Crop

Disease

Rate

Critical Comments

Preventive

30 mL/100 m²

Apply thoroughly on a monthly program starting

immediately the disease appears.

Dollar spot

(Not Tasmania,

Curative

60 mL/100 m²

Apply thoroughly under conditions of heavy

disease pressure; then treat as necessary.

Black

Helminthosporium

(QLD NSW TAS

ONLY)

60 mL/100 m²

Use high volume equipment. Low volume may

be used provided turf is irrigated thoroughly after

spraying. Apply during period of turf growth on

a monthly program.

Take-all patch

(Not SA, NT)

60 mL/100 m²

Preventive only after soil fumigation with methyl

bromide. Apply thoroughly, using high volume

equipment, 6-8 weeks after seeding. Repeat

applications (every 8 weeks in the first two

years) for continued protection.

Turf

Winter Fusarium

(NSW VIC TAS

ONLY)

60 mL/100 m²

Apply thoroughly on a monthly program from

end of March until danger of infection has

passed.

NOT TO BE USED FOR ANY PURPOSE, OR IN ANY MANNER, CONTRARY TO THIS LABEL

UNLESS AUTHORISED UNDER APPROPRIATE LEGISLATION.

GENERAL INSTRUCTIONS

Fungicide Resistance Warning

GROUP

C

FUNGICIDE

Bayfidan Turf Fungicide is a member of the DMI group of fungicides. For fungicide resistance

management the product is a Group C fungicide. Some naturally occurring individual fungi resistant

to the product and other Group C fungicides may exist through normal genetic variability in any fungal

population.

resistant

individuals

eventually

dominate

fungal

population

these

fungicides are used repeatedly. These resistant fungi will not be controlled by this product and other

Group C fungicides, thus resulting in a reduction in efficacy. Since the occurrence of resistant fungi

is difficult to detect prior to use, Bayer CropScience Pty Ltd accepts no liability for any losses that

result from failure of this product to control resistant fungi.

Mixing: Add the required quantity of Bayfidan to water in the spray vat while stirring or with agitators in

motion.

Bayfidan is a broad spectrum, systemic, foliar fungicide that is quickly taken up by plants and

translocated within the plant. Bayfidan provides protection on a monthly spray program and acts

curatively after infection has taken place. Because of its systemic activity, Bayfidan is less affected

by rainfall or irrigation than contact type fungicides.

Compatibility

Bayfidan is compatible with Baythroid® Turf Insecticide. The compatibilities given are based on world

wide experience and are considered correct. However as changes in climatic conditions can alter the

sensitivity of plants to mixtures of sprays, we accept no responsibility for the behaviour of such

mixtures.

Current Reg - Oct

2005

Bayfidan Turf Fungicide Liquid

Page 5 of 5

BACK PANEL ATTACHED TO CONTAINER

_____________________________________________________________________

Storage and disposal

Store in the closed, original container in a cool, well ventilated area. Do not store for prolonged

periods in direct sunlight. Rinse containers before disposal. Add rinsings to spray tank. Do not

dispose of undiluted chemicals on site. Dispose of at local authority landfill. If no landfill is available,

bury the container below 500 mm in a disposal pit specifically marked and set up for this purpose

clear of waterways, desirable vegetation and tree roots. Empty containers and product should not be

burnt.

Safety Directions

Will irritate the eyes and skin. Avoid contact with eyes and skin. Do not inhale spray mist. When

preparing spray, wear cotton overalls buttoned to the neck and wrist, a washable hat, elbow-length

butyl rubber gloves and goggles. If product in eyes, wash it out immediately with water. After use

and before eating, drinking or smoking, wash hands, arms and face thoroughly with soap and water.

After each day's use, wash gloves, goggles and contaminated clothing.

First Aid

If poisoning occurs, contact a doctor or Poisons Information Centre (Phone Australia: 131126).

Material Safety Data Sheet

Additional information is listed in the Material Safety Data Sheet

Exclusion of Liability

This product must be used strictly as directed, and in accordance with all instructions appearing on the

label and in other reference material. So far as it is lawfully able to do so, Bayer CropScience Pty Ltd

accepts no liability or responsibility for loss or damage arising from failure to follow such directions and

instructions.

IMPORTANT: READ ATTACHED BOOKLET BEFORE USE

APVMA Approval No.: 30676/1 L/1005

Bayfidan

and Baythroid

are Registered Trademarks of Bayer.

Bayer Environmental Science

Bayer CropScience Pty Ltd

A.B.N. 87 000 226 022

391-393 Tooronga Rd

East Hawthorn Vic 3123

Phone: 03 9248-6888

Fax: 03 9248-6800

Website: www.bayercropscience.com.au

FOR 24 HOUR SPECIALIST ADVICE

IN EMERGENCY ONLY

PHONE 1800 033 111

*Batch Number:

*Date of Manufacture:

Bayer Environmental Science

A Business Group of Bayer CropScience

6-1-2019

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection, USP 2g, to the hospital/physician level. The products have been found to contain visual grey particulate matter in reconstituted vials.

FDA - U.S. Food and Drug Administration

7-12-2018

Magnesium citrate malate as a source of magnesium added for nutritional purposes to food supplements

Magnesium citrate malate as a source of magnesium added for nutritional purposes to food supplements

Published on: Thu, 06 Dec 2018 The present scientific opinion deals with the assessment of the bioavailability of magnesium, from the proposed nutrient source, magnesium citrate malate (MgCM), when added for nutritional purposes to food supplements. MgCM is a mixed salt consisting of magnesium cations and citrate and malate anions, and with a magnesium content of 12–15%. MgCM is proposed to be used in food supplements that are intended to provide up to 300–540 mg/day magnesium. The data provided demonst...

Europe - EFSA - European Food Safety Authority Publications

10-11-2018

Pest categorisation of Popillia japonica

Pest categorisation of Popillia japonica

Published on: Thu, 08 Nov 2018 00:00:00 +0100 The Panel on Plant Health performed a pest categorisation of Popillia japonica(Coleoptera: Scarabaeidae) for the EU. P. japonica is a distinguishable species listed in Annex IAII of Council Directive 2000/29/EC. It is native to Japan but established in the USA in the early 20th century. It spreads from New Jersey to most US states east of the Mississippi, some to the west and north into Canada. P. japonica feeds on over 700 plant species. Adults attack folia...

Europe - EFSA - European Food Safety Authority Publications

3-8-2018

Scientific guideline:  Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, adopted

Scientific guideline: Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, adopted

Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance

Europe - EFSA - European Food Safety Authority EFSA Journal

31-7-2018

Public Notification: Black Rhino 25000 contains hidden drug ingredient

Public Notification: Black Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Black Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Krazzy Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Gold Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Platinum Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

10-7-2018

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

PrEP wordt binnen een onderzoekssetting voor een periode van vijf jaar verstrekt aan de hoogrisicogroep van mannen die seks hebben met mannen (MSM). Dat heeft minister Bruno Bruins (Medische Zorg) vandaag bekend gemaakt. Op basis van schattingen van het RIVM zullen ongeveer 6500 mannen hiervan gebruik gaan maken en kunnen hiermee  250 hiv-infecties per jaar worden voorkomen. Voor gebruikers gaat een eigen bijdrage gelden van maximaal 25%, dat komt overeen met ongeveer 12 euro per maand. Ook wordt hen gev...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

4-5-2018

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals, LLC of Springville, Utah is recalling Green Suma, Red Suma, Green Hulu 2, and Red Hulu 2 kratom dietary supplements sold directly to consumers via the company website from January 1st, 2018 to April l 12th, 2018 in pouches of 250g, because it has the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

15-1-2014

Revocation of wholesale distribution and manufacturing authorisations granted to Singad Pharma ApS

Revocation of wholesale distribution and manufacturing authorisations granted to Singad Pharma ApS

On 20 December 2013 and on 10 January 2014, the Danish Health and Medicines Authority decided to revoke the section 39 authorisations for wholesale distribution and manufacturing of medicinal products with the authorisation IDs 25081 and 25082 granted to Singad Pharma ApS (company number 255894).

Danish Medicines Agency

10-12-2018

EU/3/17/1906 (PTC Therapeutics International Limited)

EU/3/17/1906 (PTC Therapeutics International Limited)

EU/3/17/1906 (Active substance: Recombinant adeno-associated viral vector serotype 5 carrying the gene for the human frataxin protein) - Transfer of orphan designation - Commission Decision (2018)8634 of Mon, 10 Dec 2018 European Medicines Agency (EMA) procedure number: EMA/OD/0000002509

Europe -DG Health and Food Safety

10-12-2018

EU/3/16/1786 (PTC Therapeutics International Limited)

EU/3/16/1786 (PTC Therapeutics International Limited)

EU/3/16/1786 (Active substance: Recombinant adeno-associated viral vector serotype 2 carrying the gene for the human aromatic L-amino acid decarboxylase protein) - Transfer of orphan designation - Commission Decision (2018)8630 of Mon, 10 Dec 2018 European Medicines Agency (EMA) procedure number: EMA/OD/0000002507

Europe -DG Health and Food Safety

10-12-2018

EU/3/16/1651 (PTC Therapeutics International Limited)

EU/3/16/1651 (PTC Therapeutics International Limited)

EU/3/16/1651 (Active substance: Recombinant adeno-associated viral vector serotype 9 carrying the gene for the human E6-AP ubiquitin protein ligase) - Transfer of orphan designation - Commission Decision (2018)8632 of Mon, 10 Dec 2018 European Medicines Agency (EMA) procedure number: EMA/OD/0000002508

Europe -DG Health and Food Safety

28-11-2018

PHEBURANE (Eurocept International BV)

PHEBURANE (Eurocept International BV)

PHEBURANE (Active substance: Sodium Phenylbutyrate) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)8043 of Wed, 28 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2500/T/20

Europe -DG Health and Food Safety

30-10-2018

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Active substance: Phosphorothioate oligonucleotide targeted to transthyretin) - Transfer of orphan designation - Commission Decision (2018)7282 of Tue, 30 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/098/13/T/01

Europe -DG Health and Food Safety

29-10-2018

Replagal (Shire Human Genetic Therapies AB)

Replagal (Shire Human Genetic Therapies AB)

Replagal (Active substance: Agalsidase alfa) - Centralised - Yearly update - Commission Decision (2018)7250 of Mon, 29 Oct 2018

Europe -DG Health and Food Safety

3-7-2018

Samsca (Otsuka Pharmaceutical Europe Ltd)

Samsca (Otsuka Pharmaceutical Europe Ltd)

Samsca (Active substance: tolvaptan) - Centralised - 2-Monthly update - Commission Decision (2018) 4250 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/980/II/31

Europe -DG Health and Food Safety

6-6-2018

Stocrin (Merck Sharp and Dohme B.V.)

Stocrin (Merck Sharp and Dohme B.V.)

Stocrin (Active substance: efavirenz) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3689 of Wed, 06 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/250/T/113

Europe -DG Health and Food Safety

23-4-2018

Mylotarg (Pfizer Limited)

Mylotarg (Pfizer Limited)

Mylotarg (Active substance: gemtuzumab ozogamicin) - New authorisation - Commission Decision (2018)2504 of Mon, 23 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4204

Europe -DG Health and Food Safety